CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 38.30
-0.26 (-0.67%)
At close: Dec 5, 2025
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 13.41 billion as of December 5, 2025. Its market cap has increased by 9.08% in one year.
Market Cap
13.41B
Enterprise Value
11.92B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
38.30
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 13.41B, an increase of 77.12%. That is a compound annual growth rate of 8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 13.41B | 15.51% |
| Dec 31, 2024 | 11.61B | -7.06% |
| Dec 29, 2023 | 12.49B | -54.89% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | 74.41B | 466.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.39B |
| Hansoh Pharmaceutical Group Company | 244.94B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 113.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |